Clinical Trial News and Research

RSS
Inovio Pharmaceuticals reports release of phase II clinical trial results of ChronVac-C

Inovio Pharmaceuticals reports release of phase II clinical trial results of ChronVac-C

2 Apr 2013
Ampio Pharmaceuticals receives FDA IND approval to start clinical trial of Ampion

Ampio Pharmaceuticals receives FDA IND approval to start clinical trial of Ampion

2 Apr 2013
Research on sports-related concussion, sudden cardiac death to be presented at 2013 AMSSM Annual Meeting

Research on sports-related concussion, sudden cardiac death to be presented at 2013 AMSSM Annual Meeting

2 Apr 2013
Modifiable lifestyle factors may prevent progression of Barrett's-related esophageal cancer

Modifiable lifestyle factors may prevent progression of Barrett's-related esophageal cancer

2 Apr 2013
Adenosine Therapeutics to explore strategic options for Stedivaze

Adenosine Therapeutics to explore strategic options for Stedivaze

2 Apr 2013
Halt Medical reveals initial commercialization results, additional launch plans for Acessa System

Halt Medical reveals initial commercialization results, additional launch plans for Acessa System

1 Apr 2013
FDA approves Teva's Quartette tablets for prevention of pregnancy

FDA approves Teva's Quartette tablets for prevention of pregnancy

30 Mar 2013
Loyola researchers to evaluate impact of urinary incontinence on couple's relationship, sex life

Loyola researchers to evaluate impact of urinary incontinence on couple's relationship, sex life

30 Mar 2013
Mount Sinai experts to educate families on identifying signs, symptoms of ASD

Mount Sinai experts to educate families on identifying signs, symptoms of ASD

30 Mar 2013
MD Anderson researchers named Fellows to new AACR academy

MD Anderson researchers named Fellows to new AACR academy

29 Mar 2013
Phase 2 study of REOLYSIN meets primary endpoint in patients with squamous cell lung cancer

Phase 2 study of REOLYSIN meets primary endpoint in patients with squamous cell lung cancer

28 Mar 2013
Neurological researchers study promising new treatment for deadly brain tumors

Neurological researchers study promising new treatment for deadly brain tumors

28 Mar 2013
CureVac begins CV9104 Phase 2b clinical trial in patients with castration-resistant prostate cancer

CureVac begins CV9104 Phase 2b clinical trial in patients with castration-resistant prostate cancer

28 Mar 2013
Navidea commences enrollment in NAV4694 Phase 2b study to detect erebral β-amyloid plaque

Navidea commences enrollment in NAV4694 Phase 2b study to detect erebral β-amyloid plaque

28 Mar 2013
Virginia G. Piper Cancer Center Clinical Trials successfully tests cabozantinib

Virginia G. Piper Cancer Center Clinical Trials successfully tests cabozantinib

28 Mar 2013
Neurocrine Biosciences starts elagolix Phase IIb clinical trial for treatment of uterine fibroids

Neurocrine Biosciences starts elagolix Phase IIb clinical trial for treatment of uterine fibroids

27 Mar 2013
Lightlake to present Phase II clinical trial results of opioid antagonist nasal spray at APA Annual Meeting

Lightlake to present Phase II clinical trial results of opioid antagonist nasal spray at APA Annual Meeting

27 Mar 2013
Novel sensor improves success rate in diagnosing dysphagia

Novel sensor improves success rate in diagnosing dysphagia

27 Mar 2013
Study provides important insight into how BMT treatment works in patients with MS

Study provides important insight into how BMT treatment works in patients with MS

27 Mar 2013
Novel cell therapy effective in treating aggressive form of childhood leukemia

Novel cell therapy effective in treating aggressive form of childhood leukemia

26 Mar 2013

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback